908 Devices director Brown sells 30,000 shares
The director's sale was made under a Rule 10b5-1 trading plan adopted on November 24, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
908 Devices Inc. director Christopher D. Brown sold 30,000 common shares on November 4, 2026, at a weighted average price of $10.95 per share. The shares were sold in multiple transactions priced from $10.60 to $11.09, inclusive, under a Rule 10b5-1 trading plan adopted on November 24, 2025. He directly held 775,559 shares after the sale.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 30,000 | $10.95 | $329K |
Footnotes (2)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $11.09 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.